BURLINGTON, Vermont – June 25, 2024 – The International Academy on the Science and Impact of Cannabis (IASIC) released its official statement against the proposed rescheduling of Cannabis from Schedule I to Schedule III of the Controlled Substances Act:
As physicians and concerned citizens of the United States of America, the International Academy on the Science and Impact of Cannabis believes that re-scheduling will have immediate and irreparable harm to the public health and vehemently oppose the removal of cannabis from Schedule 1. Specific objections include (1) The Department of Health and Human Services (HHS) inappropriately changed the definition of currently acceptable medical use (CAMU); (2) Even under the new definition, cannabis still does not meet the requirements for CAMU; (3) Proper regulation of cannabis as a schedule 3 drug cannot be achieved while non-medical cannabis commerce is allowed.
“HHS and those who are pushing rescheduling of cannabis are unaware or ignoring the huge amount of science on the medical harms of cannabis. There is zero benefit and only problems to be had from rescheduling,” said Eric A. Voth, MD, FACP, President and Chairman of the Board, The International Academy on the Science and Impact of Cannabis.
An official request for a hearing with the DEA has been submitted by IASIC during the current open comment period, with its leadership urging the presentation of medical and scientific research from its physician-driven organization of international experts on cannabis.
IASIC has provided substantial education and background on the impending harm of the proposed rescheduling in its monthly speaker series on June 11th as well as on the High Truths on Drugs and Addiction podcast with episode #182: High Truths on Drugs and Addiction on Rescheduling of Marijuana with IASIC.
Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of
Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when
Background Abstract With the growing availability of cannabis and the popularization of additional routes of cannabis use beyond smoking, including edibles, the prevalence of cannabis use in pregnancy is rapidly increasing. However, the potential effects of prenatal cannabis use on fetal developmental programming remain unknown. Results We designed this study to determine whether the use
By David A. Gorelick, MD, PhD, DLFAPA, FASAMDept. of Psychiatry, University of Maryland School of MedicineEditor-in-Chief, Journal of Cannabis Research Cannabis potency, the content of ∆9-tetrahydrocannabinol (THC), usually expressed as the percentage of dry weight, has increased substantially worldwide over the past four decades [1]. This higher potency poses a risk of increased harms because
07-27-2023 Mastercard has halted cannabis purchases on its debit cards ByChrissy Sexton Earth.com staff writer Mastercard, the second-largest payment-processing corporation worldwide, has delivered a striking blow to the rapidly growing U.S. cannabis industry. In a recent directive, the company instructed its associated financial institutions to discontinue allowing marijuana-related transactions on its debit cards. This move
Courtney took her first marijuana puffs at 17. Two decades later, she was raising a toddler son and hiding her dependence from most family members. She would light her pipe more than a dozen times a day, sneaking to the garage of her Missouri home while her son napped. She still loves the earthy smell.
From left: Ken Finn, MD, IASIC Vice President; Roneet Lev, MD, IASIC Vice President; Catherine Antley, MD, IASIC Treasurer The International Academy on the Science and Impact of Cannabis is proud to announce IASIC has been selected as an organization that advises the United Nations on Drug Policy. IASIC is a new member of VNGOC, Vienna
New Jersey’s Cannabis Business is looking to significantly expand. NJ Cannabis Insider is a team of journalists from NJ.com and The Star-Ledger that are keeping up-to-date and informative information regarding issues, policies, laws, regulations, politics, and people making an impact on the cannabis industry, community, and marketplace. For more information and details – https://njcannabisinsider.nj.com/about/
This is article in its entirety including recent edits. It was originally published inWashington Post April 29, 2016 with some updates I’ve added in 2023 Bertha Madras is a professor of psychobiology at McLean Hospital and Harvard MedicalSchool, with a research focus on how drugs affect the brain. She is former deputy director fordemand reduction in
By Anthony Faiola and Catarina Fernandes Martins July 7, 2023 at 1:00 a.m. EDT PORTO, Portugal — Addiction haunts the recesses of this ancient port city, as people with gaunt, clumsy hands lift crack pipes to lips, syringes to veins. Authorities are sealing off warren-like alleyways with iron bars and fencing in parks to halt the spread of
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of
Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
